Sue Dillon
Vice President
R&D
Janssen
Romania
Biography
She leads a global team focused on combining internal and external innovation approaches to discover and develop new solutions for patients with serious immune-mediated diseases. An experienced leader in this field, Sue joined the Janssen Pharmaceutical Companies of Johnson & Johnson through Centocor R&D in 2001 and has held positions of increasing responsibility leading to her appointment as Global Therapeutic Head for Immunology. Under Sue’s leadership, Janssen has produced a strong pipeline of novel biologics and built world-class capabilities in protein drug discovery through a combination of internal efforts, acquisitions, and partnerships.
Research Interest
Immunology, translational medicine and clinical development
